Moreover, a deeper understanding of the molecular mechanisms by which manidipine modulates NFAT2 and calcium signaling pathways in cancer cells could pave the way for the development of more selective NFAT2 inhibitors or novel CCB-based therapies specifically designed for MDR reversal. This evidence concerns the gene NFATC1 and cancer.